Ulobetasol lotion - Ortho Dermatologics

Drug Profile

Ulobetasol lotion - Ortho Dermatologics

Alternative Names: Halobetasol propionate - Ortho Dermatologics; IDP-122; JEMDEL

Latest Information Update: 16 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Valeant Pharmaceuticals International
  • Developer Ortho Dermatologics
  • Class Anti-inflammatories; Antiallergics; Corticosteroids; Small molecules
  • Mechanism of Action Phospholipase A2 inhibitors; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Plaque psoriasis

Most Recent Events

  • 14 Feb 2018 Preregistration for Plaque psoriasis in USA (Topical, Lotion)
  • 14 Feb 2018 FDA assigns PDUFA action date of 05/10/2018 for Ulobetasol for Plaque psoriasis
  • 14 Feb 2018 US FDA accepts NDA for Ulobetasol for Plaque psoriasis for review
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top